Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
Inhoud geleverd door Proactive Investors. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Proactive Investors of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !
Ga offline met de app Player FM !
BenevolentAI and AstraZeneca Advance Heart Failure Treatment Discovery
MP3•Thuis aflevering
Manage episode 419619092 series 2891889
Inhoud geleverd door Proactive Investors. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Proactive Investors of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
BenevolentAI Co-Founder Dr. Ivan Griffin shared exciting news with Proactive's Steve Darling regarding the company's collaboration with AstraZeneca. Through this partnership, AstraZeneca has incorporated a novel target for Heart Failure into its discovery portfolio, thanks to BenevolentAI's AI-driven drug discovery platform. Dr. Griffin emphasized that this achievement marks a significant milestone, as it represents the first target selected from the extended collaboration with AstraZeneca. This underscores the positive progress in Target Identification within the field of Heart Failure treatment. The collaboration between BenevolentAI and AstraZeneca began in 2019, initially focusing on discovering potential treatments for idiopathic pulmonary fibrosis and chronic kidney disease. Building on this success, the collaboration expanded in January 2022 to include Heart Failure and Systemic Lupus Erythematosus, showcasing the versatility of BenevolentAI's platform across multiple therapeutic areas. One of the key strengths of this collaboration is its innovative structure, which brings together scientists and technologists from both companies to work collaboratively. By combining BenevolentAI's AI-driven platform and biomedical knowledge with AstraZeneca's scientific expertise, the collaboration has yielded novel and robust Target Identification strategies. Overall, the advancement in Heart Failure treatment discovery reflects the commitment of BenevolentAI and AstraZeneca to leveraging cutting-edge technology and collaborative efforts to address unmet medical needs and improve patient outcomes. #proactiveinvestors #benevolentai #euronextamsterdam #bai #invest #investing #investment #investor #AstraZeneca, #HeartFailure, #Lupus, #DrugDiscovery, #AIinMedicine, #PharmaCollaboration, #Biotechnology, #ClinicalResearch, #MedicalInnovation, #HealthTech, #AIHealthcare, #ChronicDisease, #MedicalResearch, #Pharmaceuticals, #HealthScience, #DataScience, #AIApplications, #BiotechPartnership, #DrugDevelopment #stockmarket #stocks #stock #stockmarketnews
…
continue reading
608 afleveringen
MP3•Thuis aflevering
Manage episode 419619092 series 2891889
Inhoud geleverd door Proactive Investors. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Proactive Investors of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
BenevolentAI Co-Founder Dr. Ivan Griffin shared exciting news with Proactive's Steve Darling regarding the company's collaboration with AstraZeneca. Through this partnership, AstraZeneca has incorporated a novel target for Heart Failure into its discovery portfolio, thanks to BenevolentAI's AI-driven drug discovery platform. Dr. Griffin emphasized that this achievement marks a significant milestone, as it represents the first target selected from the extended collaboration with AstraZeneca. This underscores the positive progress in Target Identification within the field of Heart Failure treatment. The collaboration between BenevolentAI and AstraZeneca began in 2019, initially focusing on discovering potential treatments for idiopathic pulmonary fibrosis and chronic kidney disease. Building on this success, the collaboration expanded in January 2022 to include Heart Failure and Systemic Lupus Erythematosus, showcasing the versatility of BenevolentAI's platform across multiple therapeutic areas. One of the key strengths of this collaboration is its innovative structure, which brings together scientists and technologists from both companies to work collaboratively. By combining BenevolentAI's AI-driven platform and biomedical knowledge with AstraZeneca's scientific expertise, the collaboration has yielded novel and robust Target Identification strategies. Overall, the advancement in Heart Failure treatment discovery reflects the commitment of BenevolentAI and AstraZeneca to leveraging cutting-edge technology and collaborative efforts to address unmet medical needs and improve patient outcomes. #proactiveinvestors #benevolentai #euronextamsterdam #bai #invest #investing #investment #investor #AstraZeneca, #HeartFailure, #Lupus, #DrugDiscovery, #AIinMedicine, #PharmaCollaboration, #Biotechnology, #ClinicalResearch, #MedicalInnovation, #HealthTech, #AIHealthcare, #ChronicDisease, #MedicalResearch, #Pharmaceuticals, #HealthScience, #DataScience, #AIApplications, #BiotechPartnership, #DrugDevelopment #stockmarket #stocks #stock #stockmarketnews
…
continue reading
608 afleveringen
All episodes
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.